Request a Demo
The EU's cosmetic market is governed by one of the most comprehensive regulatory frameworks in the world. However, as product innovation blurs the lines between categories, determining whether a product is a cosmetic, a biocide, a medicinal product, or a medical device has become increasingly complex. Misclassification can lead to significant market entry delays, unexpected compliance costs, and potential enforcement actions. Navigating these "borderlines" requires not only a deep understanding of Regulation (EC) No 1223/2009 (EU Cosmetics Regulation), but also a clear grasp of how it intersects with overlapping legal regimes.
Central to this process is the EU Borderline Products Manual and the specific classification logic used by regulatory authorities to assess product function, composition, and presentation. For businesses looking to launch innovative products in the EU, mastering these criteria is essential to ensuring long-term compliance and market success.
To help you navigate this intricate landscape, ChemLinked is honored to welcome Gerald Renner, Director of Technical Regulatory & International Affairs at Cosmetics Europe. Drawing on his extensive experience in EU cosmetic policy, Gerald will explore the regulatory landscape and core assessment pillars. Through practical case studies and expert classification tips, this session will provide the first-hand insights needed to ensure your products are correctly positioned in the EU market.
Notes:
1. The webinar livestreaming is freely available to all users. You are welcome to register for and participate in the webinar.
2. Kindly be aware that the access to the slides and recording is limited to ChemLinked premium members only [Upgrade now].
